Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
INNOCOS Returns to Zurich as Longevity Forces a Reckoning Across Beauty, Wellness and Consumer Brands
EIN Presswire
The flagship summit convenes leaders to address the questions the industry can no longer avoid: proof, trust, diagnostics & the rise of the clinic as a channel.
Fairclough Palmer AG Modernises Private Market Infrastructure with Swiss Stock Exchange Targeting Global Startups & SMEs
EIN Presswire
Fairclough Palmer AG introduces EquityLink, a modern digital asset exchange providing global startups and SMEs a public style marketplace to raise capital.
GlobalVentures365 Expands Focus on Investor Education and Analyst Access as Client Demand Grows
GlobeNewswire, Inc.
Aarau, Switzerland, July 17, 2026 (GLOBE NEWSWIRE) -- GlobalVentures365, an online multi-asset brokerage established in 2011, is placing renewed emphasis on the educational and analytical support available to its clients, citing sustained demand...
Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference
GlobeNewswire, Inc.
Developing bispecific Radio-DARPins to engage multiple tumor targets simultaneously, improving precision and therapeutic efficacy Presentation outlines Radio-DARPins’ ability to match target and disease biology for improved outcomes...
Recloser Market Registering a CAGR of 6.2% By Driving Types, Applications, Technology and Trends, Forecast 2035
EIN Presswire
Asia-Pacific leads the Recloser Market at 38% global share, anchored by massive state-funded grid builds in China and India.
TTM Technologies Arrives at the 2026 Farnborough International Airshow
GlobeNewswire, Inc.
SANTA ANA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of advanced electronics and interconnect solutions for aerospace, defense, and high-technology markets, today...
Precision Turned Product Manufacturing Market to Reach US$179.7 Billion by 2033, Says Persistence Market Research
EIN Presswire
Rising demand for precision components and increased adoption of CNC manufacturing technologies are driving market growth.
VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 13, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced a collaboration with Ardigen S.A., an AI-driven computational partner for modern R&D...
A Swiss Design Icon in a New Colour: MONDAINE Unveils the Limited Edition Transformative Teal Wall Clock
EIN Presswire
The iconic Official Swiss Railways Station Clock is reimagined in the Colour of the Year 2026, introducing a bold new expression of Swiss design.
Ovulation Testing Kits Market to Reach US$ 4.3 Bn by 2032 at 6.2% CAGR | Persistence Market Research
EIN Presswire
BRENFORD, LONDON, UNITED KINGDOM, July 13, 2026 /EINPresswire.com/ -- The global ovulation testing kits market is witnessing steady growth as consumers increasingly adopt home-based fertility monitoring solutions.
Seoul Pavilion Successfully Concludes at VivaTech 2026, Europe’s Largest Tech Stage
EIN Presswire
Substantial business matching outcomes lead to investment and collaboration with major European enterprises and local investors PARIS, FRANCE, July 13, 2026 /EINPresswire.com/ -- * “Seoul Night” was held successfully, attended by over 70 local...
Green Roof Market Expected to Reach US$ 10.8 Billion by 2033, According to Persistence Market Research
EIN Presswire
Growth is fueled by urbanization, climate regulations, and green building adoption.
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer.
No easy answers: European research consortia take on major challenges
GlobeNewswire, Inc.
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological...
Cytosurge’s CellEDIT Conquers "Impossible" Genome Engineering Challenges
GlobeNewswire, Inc.
A new peer-reviewed study validates CellEDIT’s ability to overcome cell-editing barriers, uncovering dermokine’s pivotal role in wound healing and skin cancer biology.
Brilliant Earth Launches The Solstice Collection, a Limited-Edition Swiss Watch Collection and its First Entry into the Category
GlobeNewswire, Inc.
SAN FRANCISCO, July 09, 2026 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. ("Brilliant Earth" or the "Company") (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced the launch of The Solstice...
Pawn Shop Queens Expands Flexible Lending with Gold, Diamond & Rolex Pawns
EIN Presswire
Growing demand for asset-backed financing highlights Pawn Shop Queens' role in providing collateral loans secured by luxury and precious-metal assets.
SEALSQ and GlobalFoundries Partner to Accelerate Post-Quantum Cryptography and Quantum Computing Technologies
GlobeNewswire, Inc.
Geneva, Switzerland, July 08, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (Nasdaq: LAES) ("SEALSQ") and GlobalFoundries (Nasdaq: GFS) (GF) today announced a strategic Memorandum of Understanding (MoU) to co-develop across secure semiconductor platforms,...
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
GlobeNewswire, Inc.
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric...
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
GlobeNewswire, Inc.
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials Dr. Ricordi to support advancement of NewcelX's Type 1 Diabetes program and...
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.